Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 39, Status: Authorised
Herbal medicinal product: Rosmarini folium, Rosmarinus officinalis L., F: Assessment finalised
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Status: Authorised
Herbal medicinal product: Rosmarini aetheroleum, Rosmarinus officinalis L., F: Assessment finalised
Herbal medicinal product: Pilosellae herba cum radice, Hieracium pilosella L., F: Assessment finalised
Herbal medicinal product: Ginseng radix, Panax ginseng C.A.Mey., F: Assessment finalised
Herbal medicinal product: Cnici benedicti herba, Cnicus benedictus L., F: Assessment finalised
List of medicines currently in PRIME scheme
Clinical Trials Information System (CTIS): Walk-in clinic April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2026, 16:00 (CEST) to 16 April 2026, 17:00 (CEST)
Article 141(1) opinions on any scientific matter: veterinary medicines